- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0032622

BC German Pharmaceuticals Private Limited
About BC German Pharmaceuticals Private Limited
Data last updated:
BC German Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 13 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24304BR2020PTC046804.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Brij Mohan Prasad and Reena Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Sri Dr. Brij Mohan Prasad Boscoman Colony More Homiopathic Bhawan Gaighat, Patna, Bihar, India – 800007.
As per the financials filed for FY 2024, the company reported a revenue of ₹98.58 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹1.17 Lakh (net margin 1.2%) and EBITDA of ₹1.75 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 106% over three years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
BC German Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0032622).
Company details
Recognitions & Rankings of BC German Pharmaceuticals
Contact details
BC German Pharmaceuticals Private Limited's registered office is in Patna, Bihar.
- Registered AddressC/O Sri Dr. Brij Mohan Prasad Boscoman Colony More Homiopathic Bhawan Gaighat, Patna, Bihar, India – 800007
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of BC German Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of BC German Pharmaceuticals Private Limited, buy the company report.
Financials of BC German Pharmaceuticals Private Limited
FY 2025 filings availableBC German Pharmaceuticals Private Limited reported revenue of ₹98.58 Lakh (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 106% over three years, including 5% growth in the latest year. EBITDA rose 94% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.75 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.17 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.8% | |||
| Net Profit Margin | 1.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of BC German Pharmaceuticals Private Limited, buy the company report.
Board of directors of BC German Pharmaceuticals Private Limited
BC German Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brij Mohan Prasad Also directs: Mobrij Foundation | Director | 13 Jul 2020 | 6 Years 4 Months | Current |
| Reena Kumari Also directs: Mobrij Foundation, Arkcon Infratech Private Limited | Director | 13 Jul 2020 | 6 Years 4 Months | Current |
| Chandradeo Prasad | Director | 13 Jul 2020 | 6 Years 4 Months | Current |
Peer comparison
BC German Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Albus Pharmaceuticals Private Limited | ₹98.77 Lakh (FY 2025) | -16.0% | Thrissur, Kerala, India | |||
| Ramakrishna Homeo Pharmaceuticals Private Limited | ₹98.62 Lakh (FY 2023) | 54.0% | Hyderabad, Telangana, India | |||
| BC German Pharmaceuticals Private Limitedthis company | ₹98.58 Lakh (FY 2024) | ₹1.17 Lakh | 1.2% | 5.0% | Patna, Bihar, India | |
| Beacon Pharmaceuticals Pvt Ltd | ₹98.08 Lakh (FY 2024) | 42.0% | Kolkata, West Bengal, India |
To see the full peer comparison of BC German Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Feb 2025 | 101072674 | Idbi Bank Limited | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving BC German Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for BC German Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for BC German Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
BC German Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Brij Mohan Prasad was appointed as Director on 13 Jul 2020.
Frequently asked questions
BC German Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 13 July 2020 (6+ years old) and is registered under CIN U24304BR2020PTC046804.
BC German Pharmaceuticals has 3 current directors:
- Brij Mohan Prasad - Director
- Reena Kumari - Director
- Chandradeo Prasad - Director
The latest financial statements of BC German Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of BC German Pharmaceuticals is U24304BR2020PTC046804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
BC German Pharmaceuticals was incorporated on 13 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Patna.
The peers of BC German Pharmaceuticals by revenue are Albus Pharmaceuticals Private Limited, Ramakrishna Homeo Pharmaceuticals Private Limited, Beacon Pharmaceuticals Pvt Ltd, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Brij Mohan Prasad was appointed as Director on 13 Jul 2020. Chandradeo Prasad was appointed as Director on 13 Jul 2020. Reena Kumari was appointed as Director on 13 Jul 2020.
Yes, BC German Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0032622).
The registered office of BC German Pharmaceuticals is at CO Sri Dr. Brij Mohan Prasad Boscoman Colony More Homiopathic Bhawan Gaighat, Patna, Bihar, India – 800007.
BC German Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.
BC German Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.

